Bococizumab

DB12456InvestigationalProtein Based Therapies

Bococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.

Mechanism: Pharmacologically active on Proprotein convertase subtilisin/kexin type 9
Curator reviewed
Code names: PF-04950615 · RN316

Resolves to

Compound

UNII45M75JVK38CAS1407495-02-6

Targets

Q8NBP7PCSK9

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

14Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bococizumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account